Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Companyâs business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
äŒæ¥ã³ãŒãSLP
äŒç€ŸåSimulations Plus Inc
äžå Žæ¥Jun 18, 1997
æé«çµå¶è²¬ä»»è
ãCEOãO'Connor (Shawn M)
åŸæ¥å¡æ°212
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 18
æ¬ç€Ÿæåšå°800 Park Offices Drive, Suite 401
éœåžRESEARCH TRIANGLE PARK
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·27709
é»è©±çªå·16617237723
ãŠã§ããµã€ãhttps://www.simulations-plus.com/
äŒæ¥ã³ãŒãSLP
äžå Žæ¥Jun 18, 1997
æé«çµå¶è²¬ä»»è
ãCEOãO'Connor (Shawn M)